文献速递基础与转化研究流行病学与生物统计

中性粒细胞激活引发的急性炎症反应可防止慢性疼痛的发展

Acute inflammatory response via neutrophil activation protects against the development of chronic pain.
PubMed 文献 · Sci Transl Med · 2022-05-11

研究对98例急性腰痛患者外周免疫细胞进行全转录组分析并随访3个月,发现疼痛缓解者出现数千个动态转录变化而持续疼痛者无变化;中性粒细胞驱动的短暂炎症反应具有保护作用。小鼠实验显示早期使用类固醇或非甾体抗炎药虽短期镇痛却延长疼痛,而中性粒细胞或其释放的S100A8/A9蛋白可预防长效疼痛;英国生物银行数据分析显示服用NSAIDs者疼痛持续风险升高。

要点

  • 急性腰痛缓解者外周免疫细胞出现数千个动态转录变化,持续疼痛者无此类变化。
  • 小鼠中早期使用类固醇或NSAID虽短期镇痛,却导致疼痛延长。
  • 英国生物银行数据中服用NSAIDs的急性背痛者疼痛持续风险升高。

核心结论

  • 尽管在早期时间点具有镇痛效果,对急性炎症的管理可能对腰痛患者的长期结局适得其反。

研究设计与样本

  • 研究对98例急性腰痛患者的外周免疫细胞进行全转录组分析并随访3个月,比较3个月时腰痛缓解与持续患者间的转录组变化。
  • 研究包含小鼠疼痛实验,以及英国生物银行中报告急性背痛受试者的疼痛轨迹分析。

主要发现

  • 腰痛缓解者在3个月内出现数千个动态转录变化,而持续疼痛者无任何动态转录变化。
  • 中性粒细胞驱动的短暂炎症反应上调对向慢性疼痛的转变具有保护作用。
  • 小鼠疼痛实验中,早期使用类固醇或非甾体抗炎药虽短期镇痛,却导致疼痛延长;其他镇痛药未观察到此种延长。
  • 小鼠中耗竭中性粒细胞延迟疼痛缓解,而外周注射中性粒细胞本身或中性粒细胞通常释放的S100A8/A9蛋白,可预防由抗炎药诱导的长效疼痛。
  • 英国生物银行中报告急性背痛的受试者分析显示,服用NSAIDs的受试者疼痛持续风险升高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The transition from acute to chronic pain is critically important but not well understood. Here, we investigated the pathophysiological mechanisms underlying the transition from acute to chronic low back pain (LBP) and performed transcriptome-wide analysis in peripheral immune cells of 98 participants with acute LBP, followed for 3 months. Transcriptomic changes were compared between patients whose LBP was resolved at 3 months with those whose LBP persisted. We found thousands of dynamic transcriptional changes over 3 months in LBP participants with resolved pain but none in those with persistent pain. Transient neutrophil-driven up-regulation of inflammatory responses was protective against the transition to chronic pain. In mouse pain assays, early treatment with a steroid or nonsteroidal anti-inflammatory drug (NSAID) also led to prolonged pain despite being analgesic in the short term; such a prolongation was not observed with other analgesics. Depletion of neutrophils delayed resolution of pain in mice, whereas peripheral injection of neutrophils themselves, or S100A8/A9 proteins normally released by neutrophils, prevented the development of long-lasting pain induced by an anti-inflammatory drug. Analysis of pain trajectories of human subjects reporting acute back pain in the UK Biobank identified elevated risk of pain persistence for subjects taking NSAIDs. Thus, despite analgesic efficacy at early time points, the management of acute inflammation may be counterproductive for long-term outcomes of LBP sufferers.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Parisien M, Lima LV, Dagostino C, et al. Acute inflammatory response via neutrophil activation protects against the development of chronic pain. Sci Transl Med. 2022. PMID: 35544595. doi:10.1126/scitranslmed.abj9954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。